Clinical trial Recruiting at 1 site Interventional Ages 4 to 13

Family guidance program for families with children who have neurodevelopmental disorders

Official title: The Effectiveness of Dialogical Family Guidance in Families With a Child With Neurodevelopmental Disorders

Run by Tampere University · NCT06322511 · Data updated 2026-11-12

This study tests a family guidance program to see if it helps families with children who have neurodevelopmental disorders by providing tailored support and information.

More Family Relations trials

Quick facts

Study typeInterventional
Ages4 Years to 13 Years
SexAll
Enrollment50 (estimated)
SponsorTampere University
Academic / other
Locations1 site (Helsinki)
StatusRecruiting
StartedJanuary 2, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedMarch 21, 2024
Trial IDNCT06322511 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are families with a child aged 4-13 years who has a clinical diagnosis of a neurodevelopmental disorder.

Probably not a fit

Families without a child diagnosed with a neurodevelopmental disorder or those who do not speak Finnish may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention, known as Dialogical Family Guidance (DFG), is designed to support families with children diagnosed with neurodevelopmental disorders by providing them with guidance and information tailored to their daily lives. The program consists of six meetings where trained professionals help families address individual concerns and share their experiences. This postdoctoral study aims to evaluate the effectiveness of DFG across different healthcare units and understand which settings and age groups benefit most from the intervention. The research will also compare outcomes between various units to optimize the delivery of support.

Why it matters

Potential benefit: If successful, this program could significantly improve family dynamics and support for families dealing with neurodevelopmental disorders.

How similar studies have gone: Previous studies have indicated positive outcomes for similar family support interventions, suggesting that this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Families with a child with clinical diagnosis within neurodevelopmental ambrella (ADHD, Tourette, Autism disorder, OCD...).
* the child must be between 4-13 years.

Exclusion Criteria:

* Families who do not understand finnish language (because they can not fill the questionnaires and professionals offering DFG are all finnish speaking). At least one parent needs to talk finnish.
* Families who are not motivated to receive DFG.
* Families who do not have a child with neurodevelopmental disorders.

Where it's running

  • Helsinki university hospital
    Helsinki, Finland
    Recruiting

Study contacts

  • Principal investigator: Diana Cavonius-Rintahaka, PhD — Tampere University, Finland
  • Study coordinator: Diana Cavonius-Rintahaka, PhD
  • Email: diana.cavonius@gmail.com
  • Phone: +358 405551511

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.